8-KExhibits & Filings

JPMORGAN CHASE & CO 8-K Report, Exhibit Filing (Apr 27, 2007)

Filed April 27, 2007For Securities:JPMJPM-PCJPM-PDJPM-PKJPM-PLJPM-PMJPM-PJAMJBVYLD

Summary

JPMorgan Chase & Co. filed a Form 8-K on April 27, 2007, reporting on Item 9.01, Financial Statements and Exhibits. The primary purpose of this filing was to include a comprehensive set of tax opinions from the law firm Davis Polk & Wardwell. These opinions pertain to various structured notes issued by the company, including Return Enhanced Notes, Buffered Return Enhanced Notes, Principal Protected Notes, and Reverse Exchangeable Notes. These notes are linked to a diverse range of underlying assets such as stock indices (S&P 500, Nikkei 225, Dow Jones EURO STOXX 50), a commodity index (Dow Jones—AIG Commodity IndexSM), specific company stocks (NYSE Euronext, AstraZeneca PLC, General Motors Corporation), and currency baskets. The filing indicates JPMorgan Chase & Co.'s ongoing activity in offering complex financial products, with tax implications being a significant aspect of these issuances, as evidenced by the inclusion of detailed legal opinions.

Key Highlights

  • 1JPMorgan Chase & Co. filed an 8-K on April 27, 2007, primarily to file exhibits.
  • 2The filing includes numerous tax opinions from Davis Polk & Wardwell, a prominent law firm.
  • 3These tax opinions relate to a variety of structured financial products, including 'Return Enhanced Notes', 'Buffered Return Enhanced Notes', and 'Principal Protected Notes'.
  • 4The underlying assets for these notes are diverse, including major stock indices (S&P 500, Nikkei 225, EURO STOXX 50), commodity indices, individual stocks, and currency baskets.
  • 5Several 'Reverse Exchangeable Notes' linked to specific companies like NYSE Euronext, AstraZeneca, and General Motors are also covered by these tax opinions.
  • 6The filing demonstrates the company's continued issuance of sophisticated debt instruments with varying risk-return profiles and maturity dates.
  • 7The inclusion of tax opinions suggests a focus on providing clarity to investors regarding the tax treatment of these complex financial products.

Frequently Asked Questions